Psychotic Episodes in Adolescents Influenced by Genetic Heritability
the Psychiatry Advisor take:
Adolescents who are eventually diagnosed with a psychosis usually have one or more psychotic experiences (PEs) early in life. However, mental health experts are unsure about the causes of PEs, and whether there are genetic or environmental factors that can lead to them. Such information could prove valuable in predicting psychotic disorders.
Helena M. S. Zavos, PhD, of King’s College London, Institute of Psychiatry, and researchers sought to find out how much of an impact genetic and environmental influences have on PEs. They examined more than 5000 adolescent twin pairs (mean [SD] age, 16.31 [0.68] years) from England and Wales.
Primary outcomes and measures were psychotic experiences assessed as quantitative traits (self-rated paranoia, hallucinations, cognitive disorganization, grandiosity, and anhedonia, as well as parent-rated negative symptoms).
Results, published in JAMA Psychiatry, found that genetic influences were apparent for all PE (15%-59%), with modest shared environment for hallucinations and negative symptoms (17%-24%). There was no linear change in heritability across the distribution of PE, with the exception of a modest increase in heritability for increasing severity of parent-rated negative symptoms. Of the PE that showed covariation, this appeared to be due to shared genetic influences (bivariate heritabilities, 0.54-0.71).
"The same genetic and environmental influences appear to drive variation across the spectrum of PE severity, which the authors suggest may point to a continuum of psychosis," Jim van Os, MD, PhD, of the Department of Psychiatry and Psychology, Maastricht University Medical Centre, The Netherlands, said in an editorial accompanying the article.
Psychotic Episodes in Adolescence Influenced by Genetic Heritability
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- The Challenges of Identifying Biomarkers of Psychiatric Illness
- FDA Approves Powerful New Opioid Despite Criticisms
- Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- FDA to Ban Most Flavored Electronic Cigarettes
- Predictors of CBT Outcomes Identified in Youths With Anxiety Disorders
- Happy Childhood Memories Associated With Better Health
- FDA Launches MyStudies Mobile App in Effort to Increase Access to Real World Patient Data
- Heart Rate Variability Predicts Treatment Response in Anxious Depression